(1 - 24 von 31
)
Ebola Vaccine Trials Carry Risks for Companies in Chase - Bloombergwww.bloomberg.com › news › articles › ebola-vacci...
www.bloomberg.com
· That's why it's imperative to cast a wide net in seeking a solution, said Matthias Schnell, a microbiologist at Thomas Jefferson University ...
Bharat Biotech, Thomas Jefferson Univ join hands for Covid ...
timesofindia.indiatimes.com
— Infectious diseases expert Professor Matthias Schnell's lab developed the vaccine in January this year, and has recently completed ... › ...
This Philly Virus Expert Is Close to Finishing Ebola Vaccinewww.phillymag.com › news › › ebola-v...
www.phillymag.com
· ebola-vaccine-philadelphia-matthias-schnell · Matthias J. Schnell is the director of the Jefferson Vaccine Center at Thomas Jefferson ...
Bharat Biotech, Thomas Jefferson U Develop COVID-19 Vax ...www.contractpharma.com › view_breaking-news
www.contractpharma.com
Matthias Schnell, director of the Jefferson Vaccine Center, Thomas Jefferson University. Contract Pharma Staff Bharat Biotech and Thomas Jefferson ...
sortiert nach Relevanz / Datum